Insitro vs LabGenius Therapeutics
Insitro vs LabGenius Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Insitro is on 62/100 and LabGenius Therapeutics on 61/100.
Where each one leads
Insitro
- domain rating: 64/100 against 46/100
- funding raised: $243M against $3.0M
LabGenius Therapeutics
- agent readiness: 47/100 against 40/100
At a glance
| Measure | Insitro | LabGenius Therapeutics |
|---|---|---|
| What it is | Data-driven drug discovery and development company using machine learning and high-throughput biology. | AI-driven drug discovery platform for rapid development of novel therapeutics. |
| Category | Healthcare, Drug Discovery, Drug Development, DNA | Biotech, Drug Discovery, AI-Driven Protein Design, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2018 | 2019 |
| Headquarters | South San Francisco, United States | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Insitro | LabGenius Therapeutics |
|---|---|---|
| Employees | 255 | Not published |
| Headcount growthLast 12 months | +10.9% | Not published |
| Total funding | $243M | $3.0M |
| Latest round | Series B | Seed |
| Valuation | $7.0B | Not published |
| LinkedIn followers | 42,173 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Insitro | LabGenius Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 61/100 |
| Traction | 60/100 | Not published |
| Team | 50/100 | 36/100 |
| Community | 8/100 | Not published |
| Search visibility | 62/100 | Not published |
| Quality | 65/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 64/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Insitro | LabGenius Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Insitro vs LabGenius Therapeutics: common questions
Which is better, Insitro or LabGenius Therapeutics?
On our 0-100 score Insitro rates higher (62/100 against 61/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Insitro and LabGenius Therapeutics compare on the numbers?
Insitro leads on domain rating (64/100 against 46/100), funding raised ($243M against $3.0M). LabGenius Therapeutics leads on agent readiness (47/100 against 40/100).
Read the full Insitro review and pricing or the LabGenius Therapeutics review and pricing. You can also browse other Insitro alternatives we track.